Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,636 | 402 | 94.3% |
| Travel and Lodging | $420.00 | 2 | 5.2% |
| Education | $44.38 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,264 | 145 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $900.21 | 38 | $0 (2023) |
| Philips Electronics North America Corporation | $556.21 | 24 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $519.12 | 32 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $502.62 | 24 | $0 (2020) |
| Olympus Corporation of the Americas | $452.03 | 5 | $0 (2017) |
| ADVANCED RESPIRATORY, INC | $314.68 | 8 | $0 (2019) |
| Mylan Specialty L.P. | $282.17 | 17 | $0 (2024) |
| Grifols USA, LLC | $260.64 | 11 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $156.59 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176.00 | 8 | GlaxoSmithKline, LLC. ($133.57) |
| 2023 | $224.94 | 12 | GlaxoSmithKline, LLC. ($198.22) |
| 2022 | $487.68 | 15 | GlaxoSmithKline, LLC. ($164.71) |
| 2021 | $318.21 | 18 | GlaxoSmithKline, LLC. ($230.37) |
| 2020 | $620.21 | 35 | GlaxoSmithKline, LLC. ($302.46) |
| 2019 | $2,042 | 103 | GlaxoSmithKline, LLC. ($436.81) |
| 2018 | $2,055 | 103 | GlaxoSmithKline, LLC. ($384.12) |
| 2017 | $2,177 | 112 | Olympus Corporation of the Americas ($452.03) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/26/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Interventional Urology | ||||||
| 10/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,477 | 2,791 | $517,703 | $263,291 |
| 2022 | 15 | 1,600 | 2,938 | $590,407 | $279,937 |
| 2021 | 15 | 1,417 | 2,574 | $555,039 | $265,928 |
| 2020 | 12 | 1,453 | 3,098 | $692,156 | $334,823 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 166 | 420 | $182,280 | $72,379 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 326 | 699 | $119,499 | $71,185 | 59.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 241 | 673 | $108,285 | $66,000 | 61.0% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 260 | 481 | $32,066 | $15,525 | 48.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 75 | $23,273 | $10,291 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $19,700 | $9,822 | 49.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 73 | 76 | $7,068 | $3,830 | 54.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 73 | 76 | $4,812 | $3,741 | 77.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 78 | $5,460 | $3,467 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 36 | $4,176 | $2,784 | 66.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 70 | 73 | $7,884 | $2,386 | 30.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 26 | 29 | $3,199 | $1,881 | 58.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 199 | 548 | $237,832 | $97,204 | 40.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 302 | 893 | $143,773 | $77,126 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 279 | 538 | $91,998 | $54,696 | 59.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 88 | 90 | $28,080 | $14,446 | 51.4% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 203 | 306 | $20,502 | $10,110 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $15,720 | $7,888 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 84 | $9,744 | $5,879 | 60.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 53 | $3,710 | $2,446 | 65.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 90 | 95 | $8,835 | $2,092 | 23.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 90 | 95 | $5,700 | $2,037 | 35.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 93 | 98 | $10,584 | $1,686 | 15.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 27 | 27 | $3,051 | $1,656 | 54.3% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 18 | 18 | $7,218 | $1,273 | 17.6% |
About Dr. Brooke Chandrasoma, M.D
Dr. Brooke Chandrasoma, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770785610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brooke Chandrasoma, M.D has received a total of $8,101 in payments from pharmaceutical and medical device companies, with $176.00 received in 2024. These payments were reported across 406 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,636).
As a Medicare-enrolled provider, Chandrasoma has provided services to 5,947 Medicare beneficiaries, totaling 11,401 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Pasadena, CA
- Active Since 06/04/2007
- Last Updated 06/26/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770785610
Products in Payments
- TRELEGY ELLIPTA (Drug) $900.22
- NUCALA (Biological) $536.58
- ANORO (Drug) $486.81
- EVIS EXERA (Device) $452.03
- STIOLTO RESPIMAT (Drug) $438.90
- inCourage (Device) $308.07
- BROVANA (Drug) $268.16
- BREO (Drug) $236.74
- The Vest System Model 105 Home Care (Device) $230.24
- ELIQUIS (Drug) $217.75
- STIOLTO (Drug) $206.76
- SYMBICORT (Drug) $197.42
- Prolastin-C Liquid (Biological) $168.57
- TUDORZA PRESSAIR (Drug) $150.85
- ZERBAXA (Drug) $134.22
- Dymista (Drug) $133.23
- FASENRA (Drug) $127.02
- Yupelri (Drug) $126.51
- BEVYXXA (Drug) $124.49
- UROLIFT (Device) $119.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882